Module 5: Polypharmacy & Deprescribing Flashcards

1
Q

Geriatric Pharmacokinetics

-Clinical considerations

A
  1. Renal Funtion
    - Calculate CrCl — creatinine is produced in skeletal muscle — If patient is frail, creatinine may appear artifically low d/t underproduction
  2. Albumin
    - Poor nutrition may result in low albumin — This will impact protein-bound agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ER visits for ADEs

-Most commonly implicated meds in patients 65+

A
  1. Warfarin
  2. Insulin
  3. Clopidogrel
  4. Aspirin
  5. Rivaroxaban
  6. Lisinopril
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 Drug classes implicated in 60% of ED visits for ADEs

A
  1. Anticoagulants
  2. Diabetes agents
  3. Opiod analgesics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Prescribing Cascade

A
  1. Drug 1 — ADE interpreted as new med condition — Drug 2 — ADE interpreted as new med condition — Drug 3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Non-Adherence Predictors

A
  1. Asymptomatic disease
  2. Inadequate follow-up
  3. Patient’s lack of insight of value of treatment
  4. Missed appointments/transportation difficulties
  5. Poor provider-patient relationship
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Interventions to improve drug compliance

A
  1. Medication reviews and counseling to identify barriers, simplify regiemns, and provide education is MOST EFFECTIVE
  2. Telephone reminders
  3. Reminder charts and calandars are LEAST effective
  4. Interactive technology to supervise, remind and monitor adherence — Limited analysis
  5. Involve a caregiver
  6. Utilize a medication tray
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Deprescribing Definition

A
  1. A Systematic process of identifying and discontinuing drugs in instances in which existing or potential harms outweigh existing or potential benefits w/in the context of an individual patient’s care goals, current level of functioning, life expectancy, values, and preferences
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Identifying Medications for Discontinuation

A
  1. Ineffective
  2. No current indication
  3. Sx’s have resolved
  4. Prescribing cascade
  5. Unacceptable tx burden and/or risk of harm
  6. Unlikely to confer benefit over patient’s lifespan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Scott’s Conceptual Framework?

A
  1. Ascertain all drugs the patient is currently taking and reasons for each
  2. Consider overall risk of drug-induced harm in indivisdual patients in determining the required intensity of deprescribing intervention
  3. Assess each drug for eligibility to be discontinued
  4. Prioritize drugs for discontinuation
  5. Implement and monitor drug discontinuation regimen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly